Bhavnagri Veer

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$5.22M

Insider Activity of Bhavnagri Veer

The largest sale of all time was on 2020-08-03 and amounted to 31553 shares of Allogene Therapeutics, Inc. for $1.16M.

Biography of Bhavnagri Veer

No biography is available at this moment.

2023-02-13SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
3,000
0.002%
$6.85$20,550-40.59%
2023-01-17SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
3,000
0.0021%
$7.04$21,120-31.37%
2022-12-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,602
0.0041%
$7.53$42,186-29.66%
2022-03-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
8,849
0.0062%
$7.68$67,962+21.54%
2021-09-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0036%
$24.77$123,845-50.78%
2021-08-16SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0036%
$21.00$104,994-41.82%
2021-07-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0035%
$21.55$107,753-43.76%
2021-06-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0038%
$25.32$126,600-38.15%
2021-05-18SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0037%
$30.00$150,000-41.11%
2021-05-17SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0037%
$28.30$141,476-37.8%
2021-04-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
10,000
0.0072%
$32.05$320,517-40.87%
2021-03-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
16,623
0.0122%
$37.95$630,798-42.72%
2020-10-06SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
10,000
0.0078%
$40.00$400,000-27.81%
2020-10-01SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
25,000
0.0187%
$36.52$912,913-23.71%
2020-09-01SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
25,000
0.02%
$35.36$883,966-10.4%
2020-08-03SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
31,553
0.0244%
$36.89$1.16M-12.71%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.